chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fainted; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP. The reporter is the patient.  A 33-year-old patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Flu vaccine, for Immunization. The following information was reported: SYNCOPE (medically significant), 1 week after the suspect product(s) administration, outcome "unknown", described as "fainted". The patient had a faint one week after the vaccination and never had it before.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
MUSCLE ACHES; INCREASED HEART RATE; FEELING WARM; CHILLS; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a 25 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient has no known allergies.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 to right arm for prophylactic vaccination.  No concomitant medications were reported. On APR-2021, Laboratory data included: Heart rate (NR: not provided) 115bpm (units unspecified).  On 07-APR-2021, the subject experienced increased heart rate. On 07-APR-2021, the subject experienced feeling warm. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced nausea. On an unspecified date, the subject experienced muscle aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from increased heart rate, chills, headache, feeling warm, nausea, and muscle aches. This report was non-serious.
Day 2 with fatigue, chills, body aches, headache and body aches with  more nausea.  No treatment thus far and unable to work today.
No additional AE's/PQC's were reported; Caller reported a temperature excursion for PROQUAD / PROQUAD lot: T0304081 was administered to (14) patients since the excursion occurred on 7/22/2021; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.     On 27-JUL-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD), 1 dosage form, lot # T0304081, expiration date reported as 07-MAR-2022 for prophylaxis (exact dose, anatomical location and route of administration were not reported).      Digital Data logger was involved. The vaccine was stored at the temperature that was reported as 13.02 degrees of Fahrenheit (F) for 1 hour and 30 minutes. There was a previous temperature excursion reported (from 14 degrees of F to 46 degrees of F (17.95 degrees of F) for 45 minutes). No symptoms were reported by the patient since the administration.  Lot # T0304081 is an invalid lot number for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD). Lot # T0304081 does not match any Company product as confirmed by Lot Verification team.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2108USA000999: US-009507513-2108USA000995: US-009507513-2108USA000996: US-009507513-2108USA000973: US-009507513-2108USA000998: US-009507513-2108USA001007: US-009507513-2108USA001006: US-009507513-2108USA001005: US-009507513-2108USA001004: US-009507513-2108USA001003: US-009507513-2108USA001002: US-009507513-2108USA001001: US-009507513-2108USA001000:
Woke up from sleep around 1am  with uncontrolled shaking, lasting approximately  1 hour. Feeling sore with headache most of next day. Stayed in bed all day with no appetite. Only drank water.. Sore shoulder and neck lasting a few more days. Feeling fine now.
A report has been received from a Health Professional concerning a 4 year old, Male subject who had been receiving Nasal FLUMIST (INTRANASAL) started on 140Jan-2014. The patient experienced EXPIRED FLUMIST QUADRIVALENT ADMINISTERED which started on 14-Jan-2014. The outcome of the event of EXPIRED FLUMIST QUADRIVALENT ADMINISTERED is unknown. The report was considered to be non-serious by the reporter.
Exactly two hours after injection, while driving, I felt light headed, dizzy, then tunnel vision as if I was going to pass out. I had muscle weakness in my arms and legs. I managed to pull over safely; Exactly two hours after injection, while driving, I felt light headed, dizzy, then tunnel vision as if I was going to pass out. I had muscle weakness in my arms and legs. I managed to pull over safely; Exactly two hours after injection, while driving, I felt light headed, dizzy, then tunnel vision as if I was going to pass out. I had muscle weakness in my arms and legs. I managed to pull over safely; Exactly two hours after injection, while driving, I felt light headed, dizzy, then tunnel vision as if I was going to pass out. I had muscle weakness in my arms and legs. I managed to pull over safely; I was nauseous and couldn't walk; I was nauseous and couldn't walk; Felt like immediate drop in blood pressure; This is a spontaneous report from a contactable consumer. A 36-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EN5318, via an unspecified route of administration at left arm on 09Feb2021 10:00 at a single dose for COVID-19 immunisation. The patient had no medical history. The patient is not pregnant. There were no concomitant medications. On 09Feb2021, exactly two hours after injection, the patient felt lightheaded and dizzy while driving, then tunnel vision as if she was going to pass out. The had muscle weakness in my arms and legs. The patient managed to pull over safely. She was nauseous and couldn't walk. This lasted about 15 minutes and then she was better. The patient felt like immediate drop in blood pressure. No treatment was received. The outcome of the events was recovered on an unspecified date.
Initial report received from a health care professional (nurse) via Novartis representative on 25 May 2010: This patient was vaccinated with MENVEO (batch no: 100001), (dose: unknown) intramuscularly on 24 May 2010. The patient was administered only the diluent portion of MENVEO. No adverse event had occurred. Follow up report received from a physician on 16 Jun 2010: The patient was not vaccinated again, no action was taken.
Initial unsolicited case received from a consumer on 22-AUG-2017. This case involves a 38-year-old male patient who was vaccinated with 0.5 ml dose of ADACEL for Immunization (batch number: U1234AA, frequency: once, expiry date and dose in series were not reported) via intramuscularly in the left deltoid on 16-AUG-2017. Patient's medical history and concomitant medications were not reported. On an unknown date, following the vaccination, patient developed pain in left arm, redness and swelling at injection site. Lab tests were not reported. As corrective treatment, patient was treated with steroid cream. Outcome of all events was reported as not recovered. List of documents held by sender: none.
10 minutes after vaccination patient developed diffuse intense itching, itching felt like it was coming from within.  Also developed some lower lip swelling. Given 50 mg IM injection of Benadryl and 40 mg PO of prednisone. Observed for 5 hours and sent home.  In the evening about 7 pm continues with itching and now lip  and tongue mild swelling.   Treated with famotidine and cetirizine.  Next day 1/13/21 developed some wheezing and ongoing tongue heaviness and lip swelling, seen in the Emergency Room and given 50 mg of Prednisone, continued on famotidine and cetirizine.  Discharged home to follow up with allergist.
Polyarticular pain (including bilateral knees) with bilateral popliteal swelling in left elbow, wrist and shoulder. Had gout in the past but controlled with diet and medications prior to vaccination. Patient stopped taking medications for it entirely. Starting approximately 1 month after vaccination, patient experienced above symptoms, with gradual worsening over time. Has significant inflammatory markers including elevated ESR, CRP and rheumatoid factor. Given methotrexate and folic acid, Humira and prednisone for inflammatory arthritis (presumed rheumatoid arthritis).
No reaction other than left arm pain with the first 4 shots.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 20Mar2021 as dose 1, single (Lot number: ER2613) at the age of 55 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "HIV positive" (unspecified if ongoing); "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Penicillin (augmentin), reaction(s): "known allergies: Penicillin (Augmentin)". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "No reaction other than left arm pain with the first 4 shots.".  Additional information: Left arm pain that evening. No reaction other than left arm pain with the first 4 shots. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Device Date was 15Sep2022. The patient did not had COVID test post vaccination. Facility type Vaccine was public Health Clinic/ Administration facility.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201167375 same patient, vaccine, event, different dose;US-PFIZER INC-202201167376 same patient, vaccine, event, different dose;US-PFIZER INC-202201167377 same patient, vaccine, event, different dose.
diarrhea; chills; aches; low grade fever; nausea; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old male patient received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6200) via an unspecified route of administration in the left arm on 23Feb2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had reported no known allergies. Concomitant medications included rosuvastatin ((MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) from unknown date for unspecified indication.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01Mar2021, the patient experienced diarrhoea for 3 days, chills, aches, low grade fever and nausea. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit. No therapeutic measures were taken as the result of adverse events. The clinical outcome of the events diarrhoea was recovered on 03Mar2021, and the events chills, aches, low grade fever and nausea were recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Vaccine administered to homebound patient; transported in qualified container in pre-drawn syringes. It was later found that the vaccine had potentially undergone a temperature excursion below 2 degrees C (0.69 degrees min during a 45 minute transportation window). Pfizer medical information has no details on excursions < 2 C of diluted vaccine. No adverse reactions noted after administration.
Patient complained of numbness and tingling on the Left arm.  After a few minutes, patient reported that symptom subsided, but remained constantly on the left hand.  Patient was able to move extremity without pain.  Patient reported that the symptom was experienced during the first dose, but only lasted for seconds.
one member said this/ narcolepsy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NARCOLEPSY (medically significant), outcome "unknown", described as "one member said this/ narcolepsy". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
10-minutes post vaccination (drive-thru vaccine site), pt called for help, was swaying in car seat, became nearly unresponsive; reported  headache, nausea, leg pain. No difficulty breathing. EMS was called. vital signs stable. Pt was transported to hospital.
Diarrhea, loratadine, resolved Nausea, ondasetron, ongoing Pain at ejection site, ongoing Headache, ibuprofen, acetaminophen
The first day, I had slight arm soreness with nothing more. When I woke up on day two, I noticed my arm had swelled more than usual (basing off my previous dose in my right arm) and was extremely hot, tender, and had two circular red patches. That night, the redness and swelling had spread into a medium sized circle, and began to itch and still be very hot upon touch. Upon looking later that night, at approximately 11pm EST, the swelling and redness had gotten larger.  On day three, the redness only got worse, and is slowly spread more over the area, with intense itching, but no longer is as sore as it was the day prior. I have iced the area, moved my arm around more to help the swelling go down, taken a hot shower, and about 600mg of Ibuprofen each day since the second dose. The only outcome to those treatments has been a significant decrease in pain level, but the swelling and redness still continues. This has all been over about a 48-72 hour time period
September had a break through case of COVID. heavy chest congestion, bad headache, sinus pressure, complete loss of taste and smell
Large red spot 4 inches below injection site, slightly sore.  Also burning chest sensations. As of today spot is gone. Chest burning is not.
Red, blanching spots on trunk. Fever 101.1 at daycare 2 hours post vaccine. Picked up and gave Tylenol. Fever returns after Tylenol wears off. Fever 103 11/10/2018 00:00. Gave Tylenol. Fever 102.3 11/10/2018 06:30.
The day of the vaccine, I had no symptoms, no fatigue, nothing. Next day I woke up and the opposite side right arm was swollen, and armpit was swollen. I had a headache, but I was still able to go to work. The swelling lasted for maybe 2-3 days and otherwise, it was fine. I just noticed the swelling moved into my right breast. I did have an ultrasound done in August 2021. They wanted to wait 6 months just to make sure the swelling would go down. No treatment, currently unknown, going for 2nd ultrasound in a couple weeks. The lump is still in my breast, but the armpit swelling is back to normal. Was referred to the Women's Center for further examination.
Patient was seen on 5/15/13 for a well child exam. He was given the vaccines listed below. Shortly after receiving the PEDIARIX he developed a local reaction with redness. He was seen again 2 days later with extensive swelling, erythema and tenderness in the entire upper thigh.
Erythema at site of vaccine, and a rash with itching on left arm and legs.  Rash is not blister or red, just raised skin with complaint of a lot of itching.
Moderate to severe vertigo starting 03/18/2021 which persisted for weeks.  Evaluated at Instacare on 4/8/2021 and was recommended to have an MRI.  The MRI authorization took a considerable amount of time and by the time it was approve my symptoms had largely resolved.  Resulted in the inability to do common activities of daily living and driving for approximately 5 weeks.
Bad stomach ache; Bruise below the band aid; Very nauseous; Arm was very painful even when  moved; redness; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Bad stomach ache), VACCINATION SITE BRUISING (Bruise below the band aid), NAUSEA (Very nauseous), VACCINATION SITE PAIN (Arm was very painful even when  moved) and VACCINATION SITE ERYTHEMA (redness) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced ABDOMINAL PAIN UPPER (Bad stomach ache), VACCINATION SITE BRUISING (Bruise below the band aid), NAUSEA (Very nauseous), VACCINATION SITE PAIN (Arm was very painful even when  moved) and VACCINATION SITE ERYTHEMA (redness). At the time of the report, ABDOMINAL PAIN UPPER (Bad stomach ache), VACCINATION SITE BRUISING (Bruise below the band aid), NAUSEA (Very nauseous), VACCINATION SITE PAIN (Arm was very painful even when  moved) and VACCINATION SITE ERYTHEMA (redness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication was reported. No treatment information was reported.   This case was linked to MOD-2021-066962 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-MAY-2021 does not contain any new information
I had my second Moderna Covid-19 vaccine at noon on Thursday, April 1. I felt lethargic evening of injection, and injection site was sore to touch for next few days with a mild case of diarrhea. Sunday, April 3 I noticed that there was a large red circle with a slight rash surrounding the injection site that hadn't been there the day before. It was gone by the next day.   The only reaction I had to the first injection was a sore arm for two days.
Pt had severe right arm pain from shoulder to hand with weakness about 2 hours after receiving vaccine in that arm.
This spontaneous report was received from a physician and refers to an approximately 66 year old female patient. Current condition included hypertension. No drug allergies reported. On 22-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 (dose unknown) (lot # K009105; expiry: 21-JAN-2016 (also reported as December 2016) in the right arm (route not specified). Other suspect therapies included influenza virus vaccine (unspecified) (manufacturer unknown) administered the same day in the left arm. Concomitant therapies included aspirin (manufacturer unknown), simvastatin (manufacturer unknown), metoprolol and EXFORGE. Approximately on an unknown date in October 2014, 4 hours after getting the vaccination the patient was presented to the emergency with a fever of 103 Fahrenheit (F) (Hospitalization), nausea (Hospitalization), body aches (Hospitalization), erythema (Hospitalization), swelling and extreme warmth at the site of PNEUMOVAX 23 injection (Hospitalization). The physician stated that the patient experienced heart rate was 110 (units unknown), white blood cell (WBC) count 20,000 (units unknown) and bilirubin 2.7 (units unknown) when the patient arrived to the hospital. The patient's most recent WBC count was 14000 (units unknown). The patient was treated with unspecified antibiotics for presumed infection fluids and unspecified topical steroid for localized reaction. Physician reported that she no longer has a fever and expressed no other complaints other than continued swelling in the arm (reported as recovering). Physician reports that the patient is still hospitalized at this time. The outcome of a fever of 103 F was reported as recovered as she no longer had fever approximately on an unknown date in October 2014. The outcome nausea, extreme warmth at PNEUMOVAX 23 injection site, body aches, erythema and was reported as resolved approximately on an unknown date in October 2014. The causality for the events was unknown. There was no product quality complaint involved. Additional information has been requested.
She shampooed her head and as she was washing her hair it was falling out/she now has a bald spot; She told her boss she didn't feel well and went home; She said that this event is very painful to her; Sore arm; he states that she got the second vaccine on Wednesday and that day she had a little sore shoulder; fatigue, so tired; light headache/Pounding in the head; This is a spontaneous report from a contactable 47-year-old female consumer or other non HCP (patient) reported for herself. A 47-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EW0150, Expiry date: unknown) via an unspecified route of administration, administered in Arm Right on 14Apr2021 around 08:00 or 09:00 (age at vaccination: 47-year-old) as a single dose for covid-19 immunization. No medical history reported. There were no concomitant medications reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6205), via an unspecified route of administration, administered in Arm Right on 24Mar2021 at 10:00 (age at vaccination: 47-year-old) as a single dose for covid-19 immunization and experienced a lot of hair fall out of her head reported as worsened on 13Apr2021. The patient had not received prior Vaccinations (within 4 weeks). On 14Apr2021, patient had a little sore shoulder, also confirmed as sore arm, headache and fatigue like 3-4 hours later. She told her boss she did not feel well and went home. She states she decided to take a shower because her head was like someone was pounding inside her head. She shampooed her head and as she was washing her hair it was falling out. She states that she now has a bald spot and people are looking at her like she has gone through chemo. She states that her daughters asked her if she had cancer and she is not telling them about it. She said that this event is very painful to her. She also stated that she has pictures from the salon. She has a light headache, and she took Tylenol this morning, but it is still persisting. However, she confirmed it is not like yesterday. She confirmed the pounding in her head has resolved. adverse events did not result in emergency room or physician office visit. The clinical outcome of sore arm, fatigue, so tired was recovering, pounding in her head has resolved on an unspecified date in 2021 and for other events outcome was unknown.  No follow-up attempts are possible; no further information expected.
Progressive loss of memory; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male patient received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 03Feb2021 at 14:00 (Lot Number: Pfizer EL 9264) at the age of 78-year-old as single dose for COVID-19 immunization. Medical history included COVID-19 (prior vaccination) and sulfa allergy. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication was not reported. On 09Feb2021, the patient experienced loss of memory. No treatment received for event. The outcome of event was unknown.  No follow-up attempts are possible. No further information is expected.
Patient received Pfizer COVID vaccine on 2/1/21, 2/27/21, 11/1/21, 6/10/22, and Moderna bivalent COVID vaccine on 11/8/22. On 2/12/23, patient tested positive for COVID in her long-term care. On 2/14/23, patient admitted to our CCU for acute hypoxemic respiratory failure due to COVID-19. Patient transferred out to med/surg unit on 2/20/23. As of today (2/21/23), patient is still admitted in our med/surg unit.